©2023 | Entheo.org
The Therapeutic Potential of Nonordinary States of Consciousness, as Explored in the Work of Stanislav Grof. Journal of Humanistic Psychology.
Predicting responses to psychedelics: a prospective study. Frontiers in Pharmacology.
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology and Therapeutics.
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology.
Psychedelics and the essential importance of context. Journalof Psychopharmacology.
Pahnke's "Good Friday Experiment”: a long-term follow-up and methodological critique. Journal of Transpersonal Psychology
Archaeological Evidence for the Tradition of Psychoactive Plant Use in the Old World. JSTOR.
Flashback: Psychiatric Experimentation with LSD in Historical Perspective. Canadian Journal of Psychiatry.
Psychiatry and psychedelic drugs. Past, present & future. Neuropharmacology.
Back to the Future — The Therapeutic Potential of Psychedelic Drugs. New England Journal of Medicine.
Why was early therapeutic research on psychedelic drugs abandoned? Psychological Medicine.
Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology.
Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. European Addiction Research.
Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects. ACS Pharmacological Translational Science.
Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Journal of Humanistic Psychology.
Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Journal of Psychopharmacology.
Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction.
Who Is Becoming Hallucinogen Dependent Soon After Hallucinogen Use Starts? Drug and Alcohol Dependence.
Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology.
Fatal and non-fatal health incidents related to recreational ecstasy use. Psychopharmacology.
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD). Journal of Psychopharmacology.
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Psychopharmacology.
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology.
Constructing drug effects: A history of set and setting. Drug, Science, Policy and Law.
Psychedelics and music: neuroscience and therapeutic implications. International Review of Psychiatry.
Adverse reactions to psychedelic drugs. A review of the literature. Journal of Nervous and Mental Disease.
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology.
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology
Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences.
Reframing Bummer Trips: Scientific and Cultural Explanations to Adverse Reactions to Psychedelic Drug Use. The Alcohol and Drugs Society.
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences. International Journal of Drug Policy.
Hallucinogen persisting perception disorder: what do we know after 50 years? Drug and Alcohol Dependence.
Patterns of ecstasy-associated hyponatremia in California. Annals of Emergency Medicine.
Harm potential of magic mushroom use: A review. Regulatory Toxicology and Pharmacology.
A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Current Topics in Behavioral Neuroscience.
Transition of Substance-Induced, Brief, and Atypical Psychosis to Schizophrenia: A Systematic Review and Meta-analysis. Schizophrenia bulletin.
Psychedelic experience dose-dependently modulated by cannabis: Results of a prospective online survey. Psychopharmacology.
Serotonin toxicity of serotonergic psychedelics. Journal of Psychopharmacology
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nature Reviews Neuroscience.
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. International Review Psychiatry.
Psychedelics and Psychedelic-Assisted Psychotherapy. American Journal of Psychiatry.
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Contextual Behavioral Science.
Increases in Psychological Flexibility Mediate Relationship Between Acute Psychedelic Effects and Decreases in Racial Trauma Symptoms Among People of Color. Chronic Stress.
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. Progressive Brain Research.
On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review. ACS Pharmacology and Translational Science.
Does psychedelic therapy have a transdiagnostic action and prophylactic potential? Frontiers in Psychiatry.
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Journal of Psychopharmacology.
Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. Journal of Psychopharmacology
Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey. British Journal of Pain.
MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder. Frontiers in Psychiatry.
Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. Headache.
Intravenous self-administration of (-)-cathinone and 2-amino-1-(2,5-dimethoxy-4-methyl)phenylpropane in rhesus monkeys. Drug and Alcohol Dependence.
Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. Behavioral pharmacology.
The serotonin 5-HT 2C receptor and the non-addictive nature of classic hallucinogens. Journal of Psychopharmacology.
Long-term follow-up of psilocybin-facilitated smoking cessation. American Journal of Drug and Alcohol Abuse.
Classic hallucinogens in the treatment of addictions. Progress in neuro-psychopharmacology.
Psilocybin-assisted treatment for alcohol dependence: a proofof-concept study. Journal of Psychopharmacology.
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized doubleblind trial. Journal of Psychopharmacology
The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology.
Long-term follow-up of psilocybin-facilitated smoking cessation. American Journal of Drug and Alcohol Abuse.
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression. Journal of Humanistic Psychology.
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry.
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects. Clinical Pharmacology and therapeutics.
Increased global integration in the brain after psilocybin therapy for depression. Nature Medicine.
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Clinical Psychiatry.
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of Psychopharmacology.
Handbook for the therapeutic use of lysergic acid diethylamide-25. Individual and Group Procedures.
LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry.
The Pharmacology of Lysergic Acid Diethylamide: A Review. CNS Neuroscience and Therapeutics.
The Pharmacology of LSD: A Critical Review. Oxford: Beckley Foundation Press & Oxford University Press.
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases. Journal of Nervous and Mental Disease.
Neural correlates of the LSD experience revealed by multimodal neuroimaging. PNAS.
The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychological Medicine.
Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide. Journal of Psychopharmacology.
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials.
Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans. Psychological Medicine.
Duloxetine inhibits effects of MDMA (“ecstasy”) in vitro and in humans in a randomized placebo-controlled laboratory study. PLoS One.
The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (“ecstasy”) in humans, Clinical Pharmacology and Therapeutics.
‘Ecstasy’ as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Social Cognitive and Affective Neuroscience.
Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. Journal of Psychopharmacology.
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? Journal of Psychopharmacology.
Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects. Plos One.
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMAAssisted Psychotherapy Compared to Paroxetine and Sertraline. Frontiers in Psychiatry.
MDMA-assisted therapy for severe PTSD: a randomized, doubleblind, placebo-controlled phase 3 study. Nature Medicine.
MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD. Journal of Psychiatric Research.
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms? Neuropharmacology and biological psychiatry.
A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy. Frontiers in Psychiatry.
Narrative identity, rationality, and microdosing classic psychedelics. International Journal of Drug Policy.
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology.
Positive expectations predict improved mental‐ health outcomes linked to psychedelic microdosing. Scientific Reports.
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. Scientific Report
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities. Journal of Psychopharmacology.
Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review. Neuroscience and Behavioral Reviews.
Implications of LSD and experimental mysticism. Journal of Religion and Health,
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology.
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. Journal of Psychopharmacology.
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology.
Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution. Frontiers in Human Neuroscience.
Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology.
Phenomenology, Structure, and Dynamic of Psychedelic States. Current topics in behavioural neuroscience.
Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Current Topics in Behavioral Neuroscience.
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. Plos One.
Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI). Frontiers in Human Neuroscience.
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation. Current Biology
Making ‘bad trips’ good: How users of psychedelics narratively transform challenging trips into valuable experiences. International Journal of Drug Policy 87: 102997.
Psychedelic harm reduction and integration: A transtheoretical model for clinical practice. Frontiers in Psychology.
Psychedelic integration: An analysis of the concept and its practice. Frontiers in Psychology.
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences.
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. PNAS.
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Neuroscience
Serotonin and brain function: a tale of two receptors. Journal of Psychopharmacology.
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. Pharmacological Reviews.
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. Journal of Neuroscience.
Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms. Neuroscience and Biobehaviroal Reviews.
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention. NeuroImage.
Brain mechanisms of hallucinogens and entactogens. Dialogues in Clinical Neuroscience.
Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex. Neuroimage.
Reduced Precision Underwrites Ego Dissolution and Therapeutic Outcomes Under Psychedelics. Frontiers in Neuroscience.
This is your Bayesian brain on drugs: Toward a predictive processing framework for psychedelic neuroscience and phenomenology.
Human hallucinogen interactions with drugs affecting serotonergic neurotransmission. Neuropsychopharmacology.
Chronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans. Neuropsychopharmacology.
Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium. Behaviour Brain Research.
Potentiation of LSD-induced stimulus control by fluoxetine in the rat. Life Science.
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport.
Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA.
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology.
Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research. Journal of Clinical Psychiatry.
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.
Indigenous Wisdom, Entheogens, and Expanded States of Consciousness for Healing and Growth. Francoise Bourzat
Safe, Therapeutic, and Sacred Journeys. James Fadiman Hofmann and Ott. (1980). LSD, my problem child (Vol. 5). New York: McGraw-Hill.
Acid dreams: The complete social history of LSD: The CIA, the sixties, and beyond
Ecstasy : The Complete Guide : A Comprehensive Look at the Risks and Benefits of MDMA
A Practical Guide to Establishing and Facilitating CareServices at Music Festivals and Other Events. MAPS
Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Journal of Humanistic Psychology
The Future Psychedelic Science
Beyond fear, MDMA, and Emotion
Exploring The New Science of Psychedelics
Psychedelics, How to Cope During a Pandemic, Taming Anxiety, and More
New Breakthroughs, Compound Comparisons and Warnings (Psilocybin/LSD/Ayahuasca/N,N-DMT/5-MeO-DMT), Treatment of Trauma, Scalable vs. Unscalable Approaches, Making Sense of “Bad” Trips, and Much More
MDMA - the creation, scheduling, toxicity, therapeutic use, and changing public opinion of what is possibly the single most important synthetic molecule ever created by our species
Psychedelics and Recreational Drugs
The Transformative Power of Mindfulness
Psychedelics and Neurostimulation for Brain Rewiring
Psychedelics for Treating Mental Disorders
The Science of MDMA & Its Therapeutic Uses: Benefits & Risks
The Science of Psychedelics for Mental Health
How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks
Psychedelics and Mortality
Psychedelics and the Self
Phenomenology of a Mushroom Trip
Subscribe for the latest news and exclusive offers.